期刊： CLINICAL ONCOLOGY, 2023; 35 (6)
Aims: Improvements in cancer treatment have led to more people living with and beyond cancer. These patients have symptom and support needs unmet by c......
期刊： CLINICAL ONCOLOGY, 2023; 35 (9)
Aims: To assess the efficacy and safety of adjuvant radiotherapy in patients with high-risk muscle-invasive bladder cancer (MIBC) following radical cy......
期刊： CLINICAL ONCOLOGY, 2023; 35 (2)
Aims: To assess the difference in survival between fertility-sparing surgery (FSS) and radical surgery and explore pregnancy outcomes after FSS in sta......
期刊： CLINICAL ONCOLOGY, 2023; 35 (4)
Aims: The current gold standard of treatment for ductal carcinoma in situ (DCIS) is surgical resection with or without adjuvant radiotherapy. However,......
期刊： CLINICAL ONCOLOGY, 2023; 35 (5)
Aims: Stereotactic body radiotherapy (SBRT) is increasingly used to treat sacral metastases. We analysed our centre's local relapse rates and patterns......
期刊： CLINICAL ONCOLOGY, 2023; 35 (9)
Aims: Osteoradionecrosis (ORN) is a serious toxicity of head and neck radiotherapy. It predominantly affects the mandible. Extra-mandibular ORN is rar......
期刊： CLINICAL ONCOLOGY, 2023; 35 (9)
There is a lack of clinical protocols for re-irradiation in paediatric central nervous system (CNS) tumours. To fill this void, the Swedish Workgroup ......
